Research ReportsEris Lifesciences Q1 Results Review - Inline; Strong Start To Business
Integration: Prabhudas Lilladher
ADVERTISEMENT
Eris Lifesciences Q1 Results Review - Inline; Strong Start To Business
Integration: Prabhudas Lilladher
The brokerage expects margins to sustain at +35% as revenue scales up from recent acquisitions which is currently operating at sub optimal profitability.
NDTV Profit’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer NDTV Profit’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.